UNSPSC 51452404: Diphenan

This classification denotes an antihelminthic agent with the molecular formula C14H13NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U129BBY8DB, chemically known as 4-(phenylmethyl)phenol, carbamate but generally known as diphenan, which bears US NIH Compound Identifier 7572. European Medicines Agency schedules Diphenan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07210MIG. The term DIPHENAN is an International Non-Proprietary Name.

UNSPSC 51452404 Diphenan is a Commodity code for pharmaceutical products, though recent state and local solicitations tagged with this code span a broader procurement activity: acquisition of naloxone and drug deactivation systems, direct-to-manufacturer pharmacy initiatives, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals distributed through cooperative purchasing vehicles. The work being solicited reflects state and local government health and emergency-response purchasing across health departments, fire departments, and HHS agencies, with issuing bodies ranging from county health systems and municipal fire departments to state health commissions and multistate cooperative purchasing alliances. The scope includes both emergency medical consumables (respiratory equipment, cardiac monitoring devices, bandaging materials, oxygen delivery systems) and pharmaceutical supply-chain optimization through direct manufacturer relationships and cooperative multi-award frameworks.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued an IFB (IFB60459723LAS) posted June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building and a response deadline of July 26, 2023. The City of Tampa issued an IFB (26P00145) posted March 25, 2026, for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, designated as a sheltered market opportunity exclusively for certified Small Local Business Enterprises with a 5% SLBE bid discount and an estimated contract value of $700,000.00. The Texas Health and Human Services Commission issued a Request for Information (HHS0017013) posted April 3, 2026, seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802) posted January 20, 2026, for generic multi-source pharmaceuticals and OTC products with a March 26, 2026, proposal deadline, extending to participating jurisdictions including Oregon.